Business context and reporting period
Lam Research supplies wafer-fabrication equipment and services, including deposition, etch, clean, and customer support. This Form 10-Q covers the fiscal quarter ended March 26, 2023 (13 weeks) and the first nine months of fiscal 2023. The filing’s period differs from the request metadata’s “2022 Q3.”
Key financial metrics
| Metric | Q3 FY2023 | Comparable period / change |
|---|---|---|
| Revenue | $3.870 billion | Down 4.7% year over year; down 27% from the December 2022 quarter |
| Gross margin | $1.606 billion; 41.5% of revenue | Prior-year quarter: $1.817 billion; 44.7% |
| Operating income | $942 million | Prior-year quarter: $1.192 billion |
| Net income | $814 million | Down 20.3% year over year |
| Diluted EPS | $6.01 | Prior-year quarter: $7.30 |
| Operating cash flow | Not separately stated for the quarter in the supplied text | Nine months: $4.056 billion, versus $2.656 billion |
| Cash, investments and restricted cash/investments | $5.6 billion | Up from $3.9 billion at June 26, 2022 |
| Debt | About $5.005 billion, primarily senior notes | No borrowings under the $1.5 billion revolving facility; compliant with covenants |
At March 26, 2023, current assets were $13.730 billion and current liabilities $4.441 billion. Inventory was $4.882 billion, up $916 million from fiscal year-end. Nine-month capital expenditures were $423 million; share repurchases were $1.148 billion and dividends paid were $676 million.
Material changes versus prior periods
- Quarterly revenue fell sequentially as wafer-fabrication equipment spending weakened, particularly in memory, and U.S. export restrictions affected shipments of equipment, parts, and services to certain China customers.
- System revenue declined to $2.256 billion from $3.548 billion in the prior quarter; customer-support-related revenue declined to $1.614 billion from $1.730 billion.
- Gross margin fell sequentially from 45.0% to 41.5%, reflecting restructuring and product-rationalization costs, lower-volume absorption, and customer/product mix.
- For the nine months, revenue increased 12.9% year over year to $14.221 billion and net income increased 9.2% to $3.708 billion. Nine-month diluted EPS rose to $27.20 from $24.02.
- Nine-month operating cash flow improved year over year, while inventory grew substantially. Operating cash flow included a $964 million inventory increase and a $392 million decrease in accounts payable, partly offset by a $1.059 billion decline in receivables.
Outlook, management commentary and risks
- Management cited weaker demand, led by memory, and said supply-chain constraints improved; the company fulfilled nearly all outstanding back-order systems.
- The company reduced its workforce by approximately 1,400 employees and recorded $107 million of restructuring charges in the quarter. It expects the plan to be substantially complete by December 24, 2023, with approximately $40 million of additional restructuring charges anticipated through that quarter.
- Management projected about $250 million of calendar-year 2023 expenditures for business-process improvements and initiatives, inclusive of the March-quarter restructuring activity. No specific revenue or earnings guidance is provided in the supplied filing text.
- Management expects existing cash and anticipated operating cash flows to fund operations, investment, debt service, capital expenditures, dividends, and repurchases for at least the next 12 months, subject to business conditions.
- Key risks include semiconductor spending volatility, customer concentration, export controls and trade restrictions affecting China, supply-chain and inflation pressures, competition and technology transitions, and execution risks from restructuring. International revenue accounted for approximately 91% of nine-month revenue.
- The company agreed to a roughly $50 million IRS adjustment for fiscal 2018 and made a partial cash settlement; remaining payment is expected under IRS requirements. Examinations of fiscal 2019 and 2020 returns had no proposed adjustments as of the filing date.
- California facility leases are supported by approximately $250 million of restricted cash collateral and include a maximum residual-value guarantee of $298.4 million. Management reported no material probable loss from known litigation or other guarantees.
Investor facts to verify
- Whether memory-market weakness and China export restrictions continue to weigh on systems revenue and customer demand.
- Whether inventory converts to shipments and cash without material obsolescence or margin pressure.
- Actual restructuring and transformation costs versus the anticipated additional $40 million and calendar-year $250 million expenditure estimate.
- Deferred-profit balance and revenue timing: deferred profit was $1.841 billion at quarter-end, while disclosed remaining contract transaction price was $2.003 billion.
- Cash generation, capital returns, debt service, tax-audit settlements, and the adequacy of liquidity under weaker industry conditions.